{"nctId":"NCT04733157","briefTitle":"The Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Caesarean Section","startDateStruct":{"date":"2021-03-23","type":"ACTUAL"},"conditions":["Postpartum Hemorrhage"],"count":1226,"armGroups":[{"label":"Study group/Group A","type":"EXPERIMENTAL","interventionNames":["Drug: Tranexamic acid injection"]},{"label":"Control group/Group B","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Normal saline placebo"]}],"interventions":[{"name":"Tranexamic acid injection","otherNames":["TXA"]},{"name":"Normal saline placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria: Women undergoing elective or emergency caesarean section with:\n\n* Estimated gestational age of 37 weeks or more\n* Live intrauterine foetus\n* Elective or emergency caesarean delivery\n* Signed informed consent\n\nExclusion Criteria:\n\n* History of coagulopathies or conditions predisposing them to thromboembolic phenomena,\n* seizure history,\n* autoimmune disease,\n* placental abruption,\n* placenta praevia,\n* abnormally adherent placentae if identified on prenatal ultrasound,\n* eclampsia or HELLP syndrome,\n* known hypersensitivity to TXA,\n* planned general anaesthesia,\n* caesarean delivery for the second twin or second/third triplet(s) after vaginal birth of the first twin,\n* poor understanding of English/Shona languages,\n* those who have received anticoagulants in the week before delivery\n* persons-under-investigation for Coronavirus disease (COVID-19) and confirmed COVID-19 positive women","healthyVolunteers":false,"sex":"FEMALE","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Postpartum Hemorrhage (PPH)","description":"Calculated estimated blood loss exceeding 1000ml. Estimated Blood Loss (EBL) was calculated using laboratory values of hemoglobin levels before and after procedure. Postpartum hemorrhage is defined as blood loss exceeding 1000mL after cesarean section.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"409","spread":null},{"groupId":"OG001","value":"399","spread":null}]},{"measurements":[{"groupId":"OG000","value":"111","spread":null},{"groupId":"OG001","value":"125","spread":null}]}]}]},{"type":"SECONDARY","title":"Blood Loss Using Hemoglobin Values","description":"Calculated blood loss using hemoglobin values. A mean value of blood loss calculated using hemoglobin values","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"537.2","spread":"758.2"},{"groupId":"OG001","value":"528.6","spread":"1020.9"}]}]}]},{"type":"SECONDARY","title":"Mean Blood Loss as Estimated by Obstetrician","description":"Visually estimated blood loss at time of caesarean section. Attending obstetrician gave an estimated value of blood loss after delivery.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"501.2","spread":"209.8"},{"groupId":"OG001","value":"495.0","spread":"188.8"}]}]}]},{"type":"SECONDARY","title":"Occurrence of Postpartum Shock","description":"Number of participants who had hypovolemic shock related to PPH as determined by assessing BP and pulse.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"603","spread":null},{"groupId":"OG001","value":"611","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Use of Supplementary Uterotonic(s)","description":"Number of women requiring supplementary uterotonics","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"93","spread":null},{"groupId":"OG001","value":"74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"252","spread":null},{"groupId":"OG001","value":"232","spread":null}]}]}]},{"type":"SECONDARY","title":"Postpartum Transfusion","description":"Number of women given postpartum transfusion","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"9","spread":null}]},{"measurements":[{"groupId":"OG000","value":"603","spread":null},{"groupId":"OG001","value":"604","spread":null}]}]}]},{"type":"SECONDARY","title":"Emergency Surgery for PPH","description":"Number of participants who had emergency surgery for PPH including caesarean hysterectomies","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"603","spread":null},{"groupId":"OG001","value":"601","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Peripartum Haemoglobin","description":"Mean change in haemoglobin concentration between the study group, calculated hemoglobin values at day 2 postpartum minus baseline hemoglobin values.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"1.4"},{"groupId":"OG001","value":"1.16","spread":"1.7"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With a Decrease in Peripartum Hemoglobin","description":"Number of participants with a drop in hemoglobin more than 2g/dL or less than 2g/dL","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"438","spread":null},{"groupId":"OG001","value":"442","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"117","spread":null},{"groupId":"OG001","value":"125","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Peripartum Haematocrit","description":"Mean change in haematocrit percentage between the study groups from baseline to day 2 postpartum","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":"4.6"},{"groupId":"OG001","value":"3.6","spread":"4.6"}]}]}]},{"type":"SECONDARY","title":"Admission Into Intensive Care Unit","description":"Number of participants transferred to intensive care unit","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"75","spread":null},{"groupId":"OG001","value":"75","spread":null}]},{"measurements":[{"groupId":"OG000","value":"525","spread":null},{"groupId":"OG001","value":"531","spread":null}]}]}]},{"type":"SECONDARY","title":"Death From Any Cause","description":"Number of participants who died from any cause","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"611","spread":null},{"groupId":"OG001","value":"613","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Blood Pressure Measurements","description":"Blood pressure at 15, 30, 45, 60, and 120 min after delivery","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"132.2","spread":"17.6"},{"groupId":"OG001","value":"131.2","spread":"18.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64.9","spread":"33.8"},{"groupId":"OG001","value":"69.1","spread":"62.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"118.3","spread":"17.3"},{"groupId":"OG001","value":"119.0","spread":"16.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61.8","spread":"14.5"},{"groupId":"OG001","value":"65.5","spread":"40.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"117.8","spread":"18.9"},{"groupId":"OG001","value":"118.7","spread":"18.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.2","spread":"11.7"},{"groupId":"OG001","value":"68.2","spread":"12.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.6","spread":"18.1"},{"groupId":"OG001","value":"124.2","spread":"16.2"}]}]}]},{"type":"SECONDARY","title":"Number of Mild Adverse Events","description":"Number of mild events of nausea, vomiting, sensation of rings or spots of light in the visual field, dizziness","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"602","spread":null},{"groupId":"OG001","value":"597","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":null},{"groupId":"OG001","value":"18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"582","spread":null},{"groupId":"OG001","value":"595","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"599","spread":null},{"groupId":"OG001","value":"599","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Severe Adverse Events","description":"* Deep vein thrombosis (if the diagnosis is confirmed by Doppler ultrasound)\n* Pulmonary embolism (if the diagnosis is confirmed by radiological examination)\n* Myocardial infarction\n* Seizure\n* Renal failure requiring dialysis","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"611","spread":null},{"groupId":"OG001","value":"613","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"611","spread":null},{"groupId":"OG001","value":"613","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"611","spread":null},{"groupId":"OG001","value":"612","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"611","spread":null},{"groupId":"OG001","value":"613","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"611","spread":null},{"groupId":"OG001","value":"613","spread":null}]}]}]},{"type":"SECONDARY","title":"Any Other Unexpected Adverse Event","description":"Number of unexpected events during and after the adminstration of study drug and duration of observation","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"611","spread":null},{"groupId":"OG001","value":"613","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of Hospital Stay","description":"Duration of hospital admission in days","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":"1.1"},{"groupId":"OG001","value":"3.5","spread":"1.3"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":611},"commonTop":["Vomiting","Dizziness","Nausea"]}}}